产品详情
"Dulbecco's 改良培养基--DMEM(Dulbecco's Modified Eagle Medium)是在MEM培养基的基础上研制的,与MEM培养基相比,氨基酸的含量增加了2倍,维生素的含量增加了4倍,同时还增加了非必须氨基酸、微量铁离子以及丙酮酸钠。DMEM培养基最初设计葡萄糖含量为1000 mg/L(低糖型),后来又发展出葡萄糖含量为4500 mg/L(高糖型),现已广泛应用于各种细胞的培养。<br/> DMEM高糖型培养基普遍应用于生长快、粘附性低的细胞、杂交瘤的骨髓瘤细胞、克隆细胞、DNA转染的转化细胞、各种原代病毒宿主细胞、单一细胞的培养以及疫苗的生产,例如利用CHO细胞表达EPO和生产乙肝疫苗。<br/> 本产品含有多类细胞培养所需的氨基酸、维生素、无机盐等多种成分,但不含蛋白质、脂类或任何生长因子,故此产品需搭配血清或无血清添加物使用。"
产品形态液体
产品浓度1×
产品规格500mL
细菌检测阴性
真菌检测阴性
支原体检测阴性
pH7.2-7.4
内毒素含量< 0.25 EU/mL
储存条件2-8℃,避光储存
运输条件常温
有效期18个月
相关文献
-
期刊:JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
DOI:10.1016/j.jddst.2024.106401
影响因子:4.5
相关产品: DMEM (High glucose) Medium, Phosphate Buffer (PBS, 1 ×), Fetal Bovine Serum, Rat Bone Marrow Mesenchymal Stem Cells
-
期刊:MOLECULAR NUTRITION & FOOD RESEARCH
影响因子:4.5
相关产品: Penicillin-Streptomycin Solution, 100 ×, DMEM (High glucose) Medium
-
Cancer-associated fibroblast-derived MMP11 promotes tumor progression in pancreatic cancer(2024)
期刊:CANCER SCIENCE
影响因子:4.5
相关产品: DMEM (High glucose) Medium, BxPC-3 Cells Line, RPMI-1640 Medium, PANC-1 Cells Line, AsPC-1 Cells Line, Penicillin-Streptomycin Solution, 100 ×
-
期刊:JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
DOI:10.1016/j.jddst.2024.106522
影响因子:4.5
相关产品: DMEM (High glucose) Medium, Phosphate Buffer (PBS, 1 ×), Fetal Bovine Serum
-
期刊:CELLULAR SIGNALLING
DOI:10.1016/j.cellsig.2024.111407
影响因子:4.4
相关产品: ROS Fluorometric Assay Kit, LDH Activity Assay Kit, Rat NT-proBNP ELISA Kit, DMEM (High glucose) Medium
-
期刊:FASEB JOURNAL
影响因子:4.4
-
期刊:EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
DOI:10.1016/j.ejpb.2024.114565
影响因子:4.4
-
期刊:CELLULAR SIGNALLING
DOI:10.1016/j.cellsig.2024.111464
影响因子:4.4
相关产品: DMEM (High glucose) Medium, Penicillin-Streptomycin Solution, 100 ×, Fetal Bovine Serum
-
期刊:CANCER BIOLOGY & THERAPY
DOI:10.1080/15384047.2024.2416221
影响因子:4.4
相关产品: MDA-MB-468-06 Cells Line, Annexin V-FITC/7-AAD Apoptosis Kit, Leibovitz's L-15 Medium, Hs 578T Cells Line, DMEM (High glucose) Medium, Penicillin-Streptomycin Solution, 100 ×
-
期刊:EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
DOI:10.1016/j.ejpb.2024.114350
影响因子:4.4